Breakthrough study shows how ketamine may ease dyskinesia in Parkinson’s patients

A recent study published in the journal Brain has revealed new insights into the neurological underpinnings of levodopa-induced dyskinesia, a common and debilitating complication of Parkinson’s disease treatment. The research explored how this condition affects the brain’s motor cortex and…